Study for biomarkers in predicting the efficacy of PD-1 monoclonal antibody in gastrointestinal cancer

ABSTRACT: Interventions: Gold Standard:Clinical outcome;Index test:multi-parameter combination model Primary outcome(s): SEN, SPE, ACC, AUC of ROC Study Design: Sequential

DISEASE(S): Gastrointestinal Cancer

PROVIDER: 2689837 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR